Although there was a significant difference in the frequency of CD4+CD25-CD69+ T cells from the bone marrow at +60 d (P = 0.046; P > 0.05 at all other time points, Table 2), it appeared that the frequencies of this subset were slightly higher than those in patients without leukemia relapse or any indication of relapse. This evidence concerns the gene CD69 and leukemia.